Palisade Bio (Nasdaq: PALI) to Present at the Biocom Global Life Science Partnering Conference
18 févr. 2022 08h30 HE
|
Palisade Bio, Inc.
CARLSBAD, Calif., Feb. 18, 2022 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI), a clinical stage biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (GI)...